
Currently out of the existing stock ratings of Steve Byrne, 124 are a HOLD (29.31%), 89 are a SELL (21.04%), 210 are a BUY (49.65%).
Analyst Steve Byrne, currently employed at BAML, has had 61.64% of price targets met with an average potential upside of 24.89%, reached in 305 days on average.
Steve Byrne has documented 815 price targets and ratings displayed on 46 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare, Technology sectors.
Most recent stock forecast was given on OLN, Olin at 30-Jun-2026.
Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) on 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%), with a performance score of 41.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Feb-2022
$119
$25.47 (27.23%)
$129
8 days ago
(09-Nov-2026)
37/52 (71.15%)
$20.63 (20.97%)
490
Buy Since 15-May-2026
$165
$71.47 (76.41%)
$190
8 days ago
(09-Nov-2026)
9/15 (60%)
$66.63 (67.73%)
397
Buy Since 22-Oct-2026
$140
$46.47 (49.68%)
$125
8 days ago
(09-Nov-2026)
7/15 (46.67%)
$41.63 (42.32%)
318
Hold Since 14-Apr-2026
$105
$11.47 (12.26%)
$189
8 days ago
(09-Nov-2026)
15/16 (93.75%)
$6.63 (6.74%)
287
Buy Since 06-Mar-2026
$170
$76.47 (81.76%)
$185
8 days ago
(09-Nov-2026)
10/18 (55.56%)
$71.63 (72.82%)
151
Which stock is Steve Byrne most bullish on?
What Year was the first public recommendation made by Steve Byrne?